Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
544445-BOM
544445-BOM

Asston Pharmaceuticals Ltd.

BSE: 544445
SME
Sector: Healthcare
Industry: Pharmaceuticals
86.00+1.5 (+1.74%)
24 Aug, 2:59 PM

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap
72.44
P/E (TTM)
18.74
P/B
1.86
P/S (TTM)
2.84
EV/EBITDA
-
CAPE (5Y)
32.80
ROE (TTM)
15.59
ROCE (TTM)
-2.87
ROA (TTM)
9.69
Avg 3Y ROE
32.87
Earnings 3Y CAGR
58.26
Sales 3Y CAGR
57.35
Sales 5Y CAGR
25.95
Debt/Equity
0.13
Consensus TP
-
Strong Buy %
-
Promoter Holding
50.66
Pledged %
0.00

Share Price

Track Asston Pharmaceuticals Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: 5.01 %
Low
80.3
High
87.0
1 Month returns: 33.87 %
Low
62.0
High
87.0
1 Year returns: -16.06 %
Low
60.0
High
111.8
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Asston Pharmaceuticals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Asston Pharmaceuticals Ltd. Shareholding Pattern

Quarterly breakdown of Asston Pharmaceuticals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Asston Pharmaceuticals Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Asston Pharmaceuticals Ltd.?
The current share price of Asston Pharmaceuticals Ltd. is ₹ 86.00 as of 24 Aug 2026.
What is the market capitalisation of Asston Pharmaceuticals Ltd.?
The market capitalisation of Asston Pharmaceuticals Ltd. stands at ₹ 72.44 Cr.
What is the PE ratio of Asston Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Asston Pharmaceuticals Ltd. is 18.74 as of the latest trailing twelve months data.
What is the ROE and ROCE of Asston Pharmaceuticals Ltd.?
Asston Pharmaceuticals Ltd. has a Return on Equity (ROE) of 15.59% and a Return on Capital Employed (ROCE) of -2.87% as per the latest financial reports.
What is the 52-week high and low of Asston Pharmaceuticals Ltd.?
The 52-week high of Asston Pharmaceuticals Ltd. is - and the 52-week low is -.
What is the dividend yield of Asston Pharmaceuticals Ltd.?
The dividend yield of Asston Pharmaceuticals Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Asston Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 1.91%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 44.46% of Asston Pharmaceuticals Ltd. shares.
What sector does Asston Pharmaceuticals Ltd. belong to?
Asston Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Asston Pharmaceuticals Ltd.?
The beta of Asston Pharmaceuticals Ltd. is -, indicating its price volatility relative to the broader market.
What is the RSI of Asston Pharmaceuticals Ltd.?
The 14-day Relative Strength Index (RSI) of Asston Pharmaceuticals Ltd. is 64.25, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.